For each library, 1010viral particles were blocked in skimmed milk 3% (w/v) and deselected twice via incubation for 1 h on Dynabeads (M-280 Invitrogen) coated with streptavidin. libraries, but reduces the clonal diversity, which may be detrimental for certain strategies. Keywords:phage display, scFv, antibody repertoire, immune library, next generation sequencing, secondary lymphoid organs == Introduction == In vitro display and selection technologies involving phage,1bacteria,2yeast3or ribosome4are commonly used to generate antibodies for research, diagnostic and therapeutic applications.5These approaches allow the isolation of antigen-specific antibody fragments from large libraries of immunoglobulin variable genes. The success of the selection process is dependent on the number, diversity and quality of the sequences present in the library. A direct correlation has been reported between the size of a library and the AZD5597 affinity IgM Isotype Control antibody (APC) of the candidates.6-8 Different strategies have been used for the diversification of antibody libraries. Oligonucleotides can be used to randomly diversify defined positions in the complementary-determining regions (CDR) of antibody genes.9,10Alternatively, naturally rearranged variable genes isolated from humans or animals can be assembled to build antibody libraries.11-13,18Natural antibody repertoires are an attractive source of diversity because, during B cell maturation, productive gene rearrangements are controlled at several stages. This proofreading mechanism increases the frequency of genes encoding a functional variable domain that are incorporated into the library and, thus, its functionality. In contrast, artificial randomization of CDR sequences lead to a higher proportion of miss-folded and non-functional polypeptides. This limitation is particularly significant when considering the CDR3 of the heavy chain (CDRH3), which can be relatively long and is more difficult to diversify using oligonucleotides while maintaining proper protein folding. On the other hand, natural antibody repertoires contain variable domains that are less-represented or suboptimal from a stability and manufacturing standpoint, and are therefore less well-suited for industrial applications. To overcome these limitations, we recently described a novel cloning strategy to recover CDRH3 sequences from human or other species. These repertoires are then integrated into human antibody frameworks selected for their representation in human repertoires AZD5597 and for their biochemical stability.14This approach allows for trapping of CDRH3 sequences from different sources into human antibody frameworks, expanding the diversity that can be exploited to generate human antibodies. For instance, CDRH3 sequences that have been biased against an antigen can be efficiently captured to generate target specific libraries and increase the frequency of isolating specific antibodies. This can be achieved by retrieving CDRH3 sequences from either immunized animals or pools of sequences that were enriched against an antigen using in vitro selection approaches such as phage display.14 When B cells encounter an antigen recognized by their B cell receptor (BCR) and encounter T cell help, they undergo affinity maturation and a selection process to produce high affinity antibodies.15These events occur in the germinal centers of secondary lymphoid tissues such as lymph nodes and spleens. The proportion of B cells in these organs is usually 25% and 40%, respectively, which are further diversified by somatic hypermutation following immunization.16B cells from secondary lymphoid organs can be fused to myeloma cells to generate monoclonal antibodies via hybridoma technology.17As the lymph nodes and the spleen are anatomically different and drain antigens via different routes,18,19differences in B AZD5597 cell populations and corresponding antibody repertoires have been reported.20These differences are further highlighted by the finding that hybridomas generated using B cells isolated from lymph nodes tend to provide higher affinity monoclonal antibodies.21,22 In this study, we explored spleen- and lymph node-derived immunoglobulin gene diversity as a source for antibody library construction. We used a CDRH3 diversity trapping approach to generate a panel of human single-chain variable fragment (scFv) libraries using CDRH3 sequences derived from spleens and lymph nodes isolated from the same group of nave or immunized mice so that these repertoires could be directly compared. These human scFv libraries were characterized by next-generation sequencing (NGS) and their relative performance was evaluated according to their binding properties following phage display selection. == Results == == Trapping murine CDRH3 repertoires into human scFv libraries == To create various CDRH3 repertoires, mice were immunized with two different antigens, i.e., human interferon gamma (hIFN) or chemokine ligand 5 (C-C motif) (hCCL5). After several booster immunizations, the sera were analyzed. They exhibited an antigen-specific IgG response and the titers were comparable between.
For each library, 1010viral particles were blocked in skimmed milk 3% (w/v) and deselected twice via incubation for 1 h on Dynabeads (M-280 Invitrogen) coated with streptavidin
